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Abstract
Background: Rotavirus (RV) nonstructural protein 4 (NSP4) is the first described viral enterotoxin, which induces
early secretory diarrhea in neonatal rodents. Our previous data show a direct interaction between RV NSP4 and the
structural protein of caveolae, caveolin-1 (cav-1), in yeast and mammalian cells. The binding site of cav-1 mapped
to the NSP4 amphipathic helix, and led us to examine which helical face was responsible for the interaction.
Methods: A panel of NSP4 mutants were prepared and tested for binding to cav-1 by yeast two hybrid and direct
binding assays. The charged residues of the NSP4 amphipathic helix were changed to alanine (NSP446-175-ala6); and
three residues in the hydrophobic face were altered to charged amino acids (NSP446-175-HydroMut). In total, twelve
mutants of NSP4 were generated to define the cav-1 binding site. Synthetic peptides corresponding to the hydrophobic
and charged faces of NSP4 were examined for structural changes by circular dichroism (CD) and diarrhea induction by a
neonatal mouse study.
Results: Mutations of the hydrophilic face (NSP446-175-Ala6) bound cav-1 akin to wild type NSP4. In contrast, disruption
of the hydrophobic face (NSP446-175-HydroMut) failed to bind cav-1. These data suggest NSP4 and cav-1 associate via a
hydrophobic interaction. Analyses of mutant synthetic peptides in which the hydrophobic residues in the enterotoxic
domain of NSP4 were altered suggested a critical hydrophobic residue. Both NSP4HydroMut112-140, that contains three
charged amino acids (aa113, 124, 131) changed from the original hydrophobic residues and NSP4AlaAcidic112-140 that
contained three alanine residues substituted for negatively charged (aa114, 125, 132) amino acids failed to induce
diarrhea. Whereas peptides NSP4wild type 112 −140 and NSP4AlaBasic112-140 that contained three alanine substituted
for positively charged (aa115, 119, 133) amino acids, induced diarrhea.
Conclusions: These data show that the cav-1 binding domain is within the hydrophobic face of the NSP4 amphipathic
helix. The integrity of the helical structure is important for both cav-1 binding and diarrhea induction implying a
connection between NSP4 functional and binding activities.

Background
Rotaviruses (RV) induce a secretory and malabsorptive
diarrhea, both of which are multi-factorial [1,2]. RV
NSP4 is the first described viral enterotoxin and induces
early secretory diarrhea in rodents [1,3-6]. Exogenously
added NSP4 mobilizes intracellular calcium ([Ca2+]i) levels
through an integrin receptor-mediated, phospholipase C
(PLC)-dependent pathway [3,6], whereas endogenously
expressed NSP4 mobilizes [Ca2+]i by a PLC-independent
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mechanism, i.e. by NSP4 functioning as a viroporin in the
endoplasmic reticulum (ER) [7,8]. These data indicate
unique activities of NSP4 in different environments. At
the exofacial surface of the plasma membrane (PM), increasing evidence has established that NSP4 activates a
calcium signal transduction pathway with the release of
chloride and water into the lumen of the gut [9,10]. It has
been hypothesized that de novo NSP4 is released from
RV- infected cells whereupon it binds to neighboring or
the same cell to initiate secretory diarrhea [5,11,12].
In addition to its enterotoxic activity, NSP4 performs
multiple intracellular functions that contribute to RV morphogenesis and replication. Early reports show NSP4 is an
ER transmembrane glycoprotein that serves as an intracellular receptor that binds double layered particles [13-16],
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and facilitates entry into the ER and acquisition of the
outer coat to form triple layered particles with a transient
ER membrane [10,15-17]. Subsequent silencing studies
(siRNA) of RV-infected cells reveal that in the absence of
NSP4 there are: (1) abnormal distributions of viral proteins
in the viroplasm [18]; (2) little to no infectious viral particles present in the cell; (3) accumulations of empty viral
particles [18,19], and (4) an up-regulation of viral transcription [19]. Taken together, NSP4 appears to function in
viral pathogenesis, replication, and morphogenesis, as well
as serving as an enterotoxin that induces calcium signaling
events and fluid loss [20].
An NSP4 C-terminal cleavage fragment (residues 112175) isolated from culture media of RV SA11-infected
(MOI = 20; Sf9 cells) or NSP4 112-175-transfected cells
show that at least a portion of NSP4 leaves the ER and
the cell [21]. Bugarcic and Taylor report the secretion of
a larger, alternately glycosylated 32 kD protein (MOI = 10,
HT29 cells) [22], but signaling function of this larger NSP4
form was not reported. Other studies note the presence
of NSP4 at multiple locations in RV SA11-infected cells
[11,23-26]. For example, Boshuizen et al report the presence of NSP4 at the basolateral surface of polarized cells in
association with the extracellular matrix proteins, lamininbeta 3 and fibronectin [11], while also showing evidence of
apical release [22]. In addition, NSP4 colocalizes with LC3,
an autophagic vesicle marker, tubulin, and VP5, a RV
viroplasm marker [12,27,28]. The recent identification of
integrins alpha 1 beta 1 and alpha 2 beta 1 as the NSP4
cell receptors support the previous observations that
NSP4 binds to the outside of the cell and stimulates a PLC
signaling pathway [12]. Our recent data show full-length
(FL) NSP4 is released from intact cells and binds neighboring cells [29]. Taken together, these data indicate that a
pool of NSP4 interacts with several host-cell molecules
that may influence its movement from the ER to the outer
leaflet of the PM and subsequent release from the cell.
Collectively, our previous data show (a) preferential
binding of FLNSP4 and NSP4114-135 peptide to caveolaelike model membranes [30,31]; (b) transport of FLNSP4
to the PM and caveolae by a Golgi-bypassing, unconventional transport pathway [26]; (c) a direct interaction
cbetween the structural protein of caveolae, caveolin-1
(cav-1), and NSP4 in yeast and mammalian cells [25]; (d)
the presence of full length, endoglycosidase H (Endo-H)sensitive FLNSP4 in caveolae microdomains isolated from
PM fractions of infected cells [26]; (e) FLNSP4 traffics to
the PM, exposing the C-terminus to the extracellular
space and subsequently is released from the cell; and
(f ) Kd analyses of FLNSP4 and cav-1 peptides showed
preferential binding to the N-terminus of cav-1, with an increased affinity in the presence of cholesterol-rich
model membranes, as well as a direct interaction between
FLNSP4 and cholesterol [32].
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Cav-1 is localized in the intestine, interacts with cholesterol, functions to transport de novo synthesized cholesterol to and from the ER and caveolae, and organizes
signaling molecules, including those regulating calcium
homeostasis [33-35]. The NSP4 binding site for cav-1
maps to aa 114-135, the enterotoxic domain, using in vivo
yeast two-hybrid (Y2H) assays, in vitro peptide binding assays, co-immunoprecipitation (co-IP) reactions, and laser
scanning confocal microscopy (LSCM) co-localization and
fluorescent resonance energy transfer (FRET) analyses [25].
The enterotoxic domain of NSP4 interacts with both the
N- and C-termini of cav-1 [36]. This result was surprising
as cav-1 forms a hairpin loop in the cytofacial leaflet of the
PM such that the two termini appear physically separated
in the cytosol of the cell [37-41].
The goal of this study was to resolve the details of the
NSP4-cav-1 interaction by (i) elucidating the type of
interaction between NSP4 and cav-1, (ii) mapping the
precise binding residues, and (iii) determining the extent
to which interaction with cav-1 influences enterotoxic
activity.

Results
The hydrophobic face of the NSP4 amphipathic alpha
helix (AAH) binds cav-1

To identify the face of the amphipathic helix that binds
cav-1, a 3-D structural model was generated using the
crystallographic determinants for NSP4 95-135 [42] and
visualized using PyMol (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC). The six
charged residues between 114 and 135 were mutated
to alanine (D114A, K115A, R119A, E125A, D132A, and
K133A) in FLNSP4-Ala6, and three hydrophobic residues
were mutated to charged residues (I113R, V124K, and
Y131D), in FLNSP4-HydroMut (Figure 1A and B, Table 1).
The interactions of these FLNSP4 mutants with cav-1
were evaluated by yeast-two-hybrid (Y2H) assays by
reacting the Gal4 activation domain fusion protein
with the NSP4:Gal4 binding domain fusion proteins.
The plasmids were co-transformed into the yeast strain
MaV203 as previously described [25]. The growth patterns of the co-transformed yeast confirmed the activation of the three reporter genes of the Y2H assay and
established FLNSP4-Ala6 as positive for interacting with
cav-1. In contrast, the FLNSP4-HydroMut failed to activate
the three reporter genes indicating a lack of binding (data
not shown).
Previous Y2H assays show that the reactions are
clearer in the absence of the first two N-terminal hydrophobic domains of FLNSP4 [25]. Therefore, new mutants,
NSP4, NSP4Ala6, and–HydroMut, that lack the first two
hydrophobic domains, were cloned into the Gateway® entry
clone, pENTR11, and inserted into the pDest32 plasmids
to produces the Gal4 binding domain fusion proteins. The
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Figure 1 (See legend on next page.)
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(See figure on previous page.)
Figure 1 A and B Organization of the Polar and Hydrophobic faces of the NSP4 crystal structure of the enterotoxic AAH (A and B
respectively). A shows the acidic amino acids, D114, E122, E125 and D132 depicted in a maroon color. The basic amino acids K115, R119, R129
and K133 are shown in blue. B shows the hydrophobic amino acids of the AAH of NSP4 I113, L116, V124, L127, I130, Y131 and L134 in purple.
C PyMol representations of the hydrophobic face of NSP4-(residues 46-175) and mutants. Amino acids in purple (I113, V124 and Y131) are indicated by
arrows represent the wild type NSP4. Eight mutant clones are viewed below the wild type NSP4. The mutations, I113R, V124D and Y131K are orange,
and amino acids that are mutated to alanines are shown as blue. To the right of each represented clone, the results of the yeast two hybrid and the
peptide binding assays are given.

Gateway® entry clone, pECav-1 was used to insert the
cav-1 sequence into the pDest22 plasmid that produces a
fusion protein with the Gal4 activating domain for Y2H
assays [25].
The growth patterns of the co-transformed yeast were
monitored for activation of transcription from three chromosomally integrated reporter genes Ura3, His3, and lacZ
(Table 2). To assess the success of the co-transformation
and transcription activation, four growth phenotypes were
determined using media lacking the following amino acids:
1) Leucine and tryptophan; 2) Leucine, tryptophan, and
histidine with 50 mM 3-Amino-1,2,4-Triazol (3-AT);
3) Leucine, tryptophan, and uracil; 4) Leucine, tryptophan,
with 5-fluoroorotic acid (5FOA). The growth patterns were
qualitatively scored and compared to the phenotypes that
are defined in the Y2H manual [43] as positive and negative interactions (data not shown).
Induction of the lacZ reporter gene was confirmed
using the quantitative chlorophenol red-beta-D-galactopyranoside (CPRG) assay for beta-galactosidase activity and
reported as beta-galactosidase units (BGU). The negative
yeast control had 0.134 BGU while truncated NSP446-175
had 1.39 BGU. NSP4HydroMut and NSP4Ala6 had 0.105 and
1.822 BGU, respectively, indicating a negative and positive
interaction, respectively (Table 2).
The growth patterns of the co-transformed yeast confirmed the activation of the three reporter genes of the
Y2H assay. The N-terminally deleted NSP4Ala6 showed a
positive reaction for interacting with cav-1. In contrast,
the N-terminally deleted NSP4HydroMut failed to activate
the three reporter genes. These data suggested alteration
of the hydrophobic face of the amphipathic alpha helix
of the NSP4 enterotoxic domain (I113, V124, and Y131),
failed to bind cav-1.
NSP4HydroMut failed to associate with cav-1 by a peptide
binding/pull-down assay

To confirm the Y2H results, newly synthesized cav-1
peptides (amino acids 2-31, 76-101, and 161-178) were
bound to sepharose beads, and reacted with yeast lysates
expressing FLNSP4, FLNSP4-Ala6, or FLNSP4-HydroMut
(Figure 2A). As expected, Western blot analyses of precipitated lysates with sepharose beads only and precipitated
untransformed lysates did not demonstrate NSP4-specific
bands (Figure 2A, lanes 1-4, 8, and 12). In FLNSP4

containing lysates, NSP4 was pulled down by cav2-31
and showed NSP4-specific bands at 28, 26 and 20 kD
that correspond to double, single and non-glycosylated
forms of NSP4, respectively (Figure 2A, lane 5). FLNSP4Ala6 also bound to cav2-31 but exhibited only two
bands at ~26 and 20 kD (Figure 2A, lane 6). The double
glycosylated form was not detected under these conditions.
A 26 kD, NSP4-specific band similarly was visible with
both FLNSP4 and FLNSP4-Ala6 when captured with
cav161-178 (Figure 2A, lanes 9 and 10). In agreement with
the Y2H data, FLNSP4-HydroMut lysates failed to react
with either of the sepharose-bound peptides, cav-12-31 or
cav-1161-178 (Figure 2A, lanes 7 and 11). These results support the hypothesis that the binding of NSP4 to cav-1 is via
a hydrophobic interaction.
To illustrate FLNSP4 and NSP446-175 yield similar results, the same cav-1 peptides were tested with NSP446-175,
NSP4Ala6 and NSP4HydroMut and yielded identical results as
that acquired with FLNSP4, FLNSP4-Ala6, and FLNSP4HydroMut (data not shown). The three hydrophobic
amino acids changed in NSP4HydroMut, I113R, V124K, and
Y131D, appeared to be important for the binding to cav-1.
Peptides corresponding to both the N- and C-terminal regions of cav-1 (2-31, 19-40 and 161-178) interacted with
NSP4 but cav-1 residues 76-101 failed to bind NSP4 (data
not shown) as previously reported [36].
All three NSP446-175HydroMut revertants associate with
cav-1 by Y2H analyses and peptide pull-down assays

To further localize the cav-1 binding domain of the Nterminal deletion mutant (NSP446-175), each of the mutant residues in NSP4HydroMut individually were reverted
back to the original hydrophobic amino acid [Rev1(113I),
Rev2(124 V) and Rev3(131Y), Table 1], and transformed
into yeast with cav-1 for evaluation by Y2H assays. All
three revertants showed growth patterns of the cotransformed yeast confirming the activation of the three reporter genes of the Y2H assay (data not shown). Induction
of the lacZ reporter gene was confirmed using the quantitative CPRG assay for beta-galactosidase activity reported
as BGU. The revertants (Rev1, Rev2, Rev3) yielded 3.941,
3.042, and 3.195 BGU, respectively, which was 30 times
higher than the negative yeast control (0.134 BGU), and
over 2 times higher than NSP446-175 (1.39 BGU) (Table 2).
These data indicated all 3 revertants interacted with cav-1,
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Table 1 NSP4 constructs and primers
Name of constructa

Amino acid changesb

Primers for site directed mutagenesisc

FLNSP4 Ala (1-175)

D114A,K115A,R119A

BP3 5′ TACCGCGGCCGCGGAAAAGCTTACCGACCTCA 3′

E124A,D132A,K133A

BP28 5′ TACTTGTTCAATTTCAGCTGTAGTCAATGCGGCAATCATTT 3′
BP29 5′AAATTGAACAAGTAGCTTTGCTTAAACGCATTTACGCTGCATTGA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

NSP4 Ala (46-175)

FLNSP4 HydroMut (1-175)

D114A,K115A,R119A

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′

E124A,D132A,K133A

BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

I113R,V124K,Y131D

BP3 5′ TACCGCGGCCGCGGAAAAGCTTACCGACCTCA 3′
BP31 5′ TTGTTCAATTTCACGTGTAGTCAATTTGTCACGCATTTCT 3′
BP30 5′ TGAAATTGAACAAAAAGAGTTGCTTAAACGCATTGACGATAA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

NSP4 HydroMut (46-175)

I113R,V124K,Y131D

Rev1 (46-175)

I113,V124K,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′
BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP34 5′ TTGTTCAATTTCACGTGTAGTCAATTTGTCAATCATTTCT 3′
BP30 5′ TGAAATTGAACAAAAAGAGTTGCTTAAACGCATTGACGATAA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

Rev2 (46-175)

I113R,V124,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP31 5′ TTGTTCAATTTCACGTGTAGTCAATTTGTCACGCATTTCT 3′
BP32 5′ TGAAATTGAACAAGTAGAGTTGCTTAAACGCATTGACGATAA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

Rev3 (46-175)

I113R,V124K,Y131

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP31 5′ TTGTTCAATTTCACGTGTAGTCAATTTGTCACGCATTTCT 3′
BP33 5′ TGAAATTGAACAAAAAGAGTTGCTTAAACGCATTTACGATAA 3′
BP4 5′ TCTAGATATCTCGAGTTACATTGCTGCAGTCACTT 3′

Rev2 116,124,127A

I113R,L116A,V124A,L127A,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP80 5′ TTCAATTTCACGTGTAGTTGCTTTGTCTGC 3′
BP81 5′ AAATTGAACAAGCAGAGTTGGCAAAACGCGCAGA 3′
BP4′ 5′ TTACATTGCTGCAGTCACTTCTCTTGGTT 3′

Rev2 116A

I113R,V124,L116A,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP91 5′ TTGTTCAATTTCACGTGTAGTTGCTTTGTCAATCATTTCT 3′
BP32 5′ TGAAATTGAACAAGTAGAGTTGCTTAAACGCATTGACGATAA 3′
BP4′ 5′ TTACATTGCTGCAGTCACTTCTCTTGGTT 3′

Rev1,2 127A

I113,V124,L127A,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP89 5′ AATGCGTTTTGCCAACTCTT 3′
BP88 5′ AAGTGGAGTTGGCAAAACG 3′
BP4′ 5′ TTACATTGCTGCAGTCACTTCTCTTGGTT 3′

Rev1 124,127A

I113,V124A,L127A,Y131D

BP23 5′ ATTTAACCATGGCACTACATAAAGCATCCATTCCA 3′
BP91 5′ TTGTTCAATTTCACGTGTAGTTGCTTTGTCAATCATTTCT 3′
BP81 5′ AAATTGAACAAGCAGAGTTGGCAAAACGCGCAGA 3′
BP4′ 5′ TTACATTGCTGCAGTCACTTCTCTTGGTT 3′

a

Names of mutants of full length NSP4 or NSP4 46-175 that were cloned into the yeast two hybrid vectors, pDest32 and pDest22 and the yeast expression
vector, pYDest52.
b
Native amino acids of NSP4 46-175 that were mutated or reverted back to the original amino acids.
c
The names and the sequences of the oligonucleotides that were used to clone the mutant clones.
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Table 2 Phenotypes of pD32-NSP4 mutants plus pD22-caveolin-1a
CSM Leu-Trp-His- + 3AT

CSM Leu-Trp-Ura-

CSM Leu-Trp- + 0.2% 5FOA

beta-gal

Phenotypesc

b

50 mM

Units

Negative Control

+/−

-

-

0.134

Negative

NSP4 46-175

+/−

-

+/−

1.390

Positive

NSP4 Ala

-

-

+/−

1.822

Positive

NSP4 HydroMut

-

+/−

+

0.105

Negative

Rev1

-

-

+/−

3.941

Positive

Rev2

+/−

-

+/−

3.042

Positive

Rev3

+/−

+/−

-

3.195

Positive

Rev1,2 127A

+/−

-

+/−

2.581

Positive

-

-

+/−

4.044

Positive

Rev1 124,127A
Rev2 116A
Rev2 116,124,127A

-

-

+/−

0.165

Negative

+/−

+/−

+/−

0.056

Negative

a

Colonies were grown on CSM Leu-Trp- and replica plated onto CSM Leu-Trp-His with 50 mM 3AT; CSM Leu-Trp-Ura-; and CSM Leu-Trp- with 0.2% 5FOA.
Beta-galactosidase activity was quantitatively measured by CPRG assays.
c
The phenotype was determined by combining the results of growth on differential media and beta-galactosidase activity.
The negative control and mutants NSP4 clones that did not interact with caveolin-1 are in bold letters.
b

so a single hydrophobic residue between NSP4 124-131
was sufficient for binding.
To validate the Y2H data, cav-1 peptides (aa 2-31, 76101, and 161-176) were bound to sepharose beads and
tested for capturing each of the individual revertants
(Figure 2B). Western blot analyses of Rev1, Rev2, and
Rev3 when reacted with sepharose beads only or untransformed yeast lysates (InVSc1) showed no bands
(Figure 2B, lanes 1-4, 8 and 12). An NSP4-specific band
was observed at 17 kD with all three revertants when
reacted with both cav2-31 and 161-178 (lanes 5, 6, 7 and 9,
10, 11 respectively), which is the correct theoretical molecular weight of NSP4 46-175. NSP4-specific bands were
absent when the lysates were incubated with cav76-101 (data
not shown). These data support the in vivo Y2H results
showing cav-1 interacted with each of the revertants.
NSP4- and cav-1-fusion proteins are present in the
co-transformed yeast

To verify the presence of the NSP4 and cav-1 GAL-4 fusion proteins in the yeast that showed no binding to
cav-1 in the Y2H assay, the co-transformed lysates were
probed with either anti-NSP4150-175 (Figure 3A and C)
or anti-cav-12-31 (Figure 3B and D) peptide-specific antibodies. Controls included untransformed MaV203 yeast
lysates. The controls failed to show an antibodyspecific band at the correct molecular weight of the
fusion proteins for both the activating domain (AD)NSP4 and binding domain (BD)-cav-1. However, a
non-specific band at ~28 kD was observed when blotted
with both antisera (Figure 3, lane 1). All NSP4 and cav-1
fusion proteins tested expressed at the correct molecular
weight (34.4 kD and 34.9 kD, respectively) and were

reactive with NSP4- (Figure 3, panels A&C) and cav-1
peptide-specific antisera (panel B&D). These data established that the encoded sequences from both plasmids
were translated as fusion proteins in the co-transformed
yeast, even when no reactivity was detected.
Four mutations of the revertants demonstrate a key
hydrophobic residue in binding cav-1

Four additional mutants were generated from the revertants, Rev2 116,124,127A; Rev2 116A; Rev1,2 127A; and
Rev1 124 ,127A (Tables 1 and 2, Figure 1C), individually
were co-transformed with cav-1 and were evaluated by
Y2H analyses. Rev1,2 127A and Rev1 124,127A revealed
positive patterns of growth for a protein:protein interaction while Rev2 116,124,127A and Rev2 116A demonstrated negative growth patterns (data not shown). All four
revertant mutant clones quantitatively were tested for betagalactosidase activity. Rev2 116,124,127A and Rev2 116A
both demonstrated beta-gal activity of 0.056 and 0.165
BGU, respectively, which was less than or equivalent to
values of the negative control (0.134 BGU) (Table 2). In
contrast, Rev1 124,127A and Rev1,2 127A displayed β-gal
activity of 4.044 and 2.581 BGU respectively, which was approximately 20-30 times higher than that of the negative
control (0.134 BGU) (Table 2). These data signify that Rev1
124,127A and Rev1,2 127A bound cav-1, whereas Rev2
116,124,127A and Rev2 116A lacked binding to cav-1.
In vitro cav-1 peptide binding assays of the revertants
confirm the Y2H results

Previously, we had reported that cav19-40 binds to NSP4
with a higher affinity than cav2-20 and cav161-178 [32].
Therefore, we employed the cav19-40 peptide for the
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Figure 2 Binding of Caveolin-1 Peptides to NSP4 Constructs. Panel A: Transduced yeast lysates expressing full-length- NSP4,-NSP4-Ala6
and -NSP4-HydroMut (FLNSP4, FLNSP4-Ala6, and FLNSP4-HydroMut) were incubated with CNBr-activated sepharose 4B beads bound by the
N-terminal (cav-12-31), C-terminal (cav-1161-178), or beads only. The beads were washed and the captured proteins separated by SDS-PAGE,
transferred to nitrocellulose, and probed using rabbit anti-NSP4150-175. Controls (lanes 1-4) show the absence of non-specific binding to the sepharose
beads with all lysates tested. Lanes 5-7 show the reactivity of FLNSP4 and-NSP4 mutants with cav-12-31. Only the FLNSP4-HydroMut failed to bind the
N-terminal caveolin-1 peptide. The same binding pattern was observed when FLNSP4 and -NSP4 mutant proteins where incubated with cav-1161-178
(lanes 9, 10, and 11). InVSc1 alone showed no NSP4-specific bands using either peptide (lanes 8 and 12). Panel B: Western blot analyses
of CNBr-activated sepharose 4B beads that were bound by cav-12-31, cav161-178 or no peptide and reacted with yeast lysates expressing Rev113I, Rev124V,
Rev131Y. The peptide-bound proteins were detected by Western blot using rabbit anti-NSP4150-175. Lanes 1-4 demonstrate that the NSP4 proteins failed
to bind the sepharose beads alone with all lysates tested. Lanes 5, 6, and 7 indicate that all three revertant NSP4 proteins bound to the N-terminal
peptide, Cav-12-31. The same binding pattern was observed with the C-terminal peptide, cav-1161-178 (lanes 9, 10, and 11), while InVSc1 failed to bind
either peptide (lanes 8 and 12).

remainder of the binding studies. Cav19-40 and cav161-178
were bound to sepharose beads, reacted with the revertant mutants expressed in yeast, and assessed by Western
blot. Lysates from untransformed InVSc1 yeast (Figure 4,
lanes 7 and 14) and all NSP4 mutant proteins incubated with only sepharose beads demonstrated no reactivity to NSP4 by Western blot (data not shown).
Further, no NSP4 specific bands were detected by Western
blot of lysates expressing Rev2 116,124,127A, Rev2 116A
or NSP4HydroMut incubated with cav19-40 or cav161-178
(Figure 4, lanes 2, 3, 6; lanes 9, 10, 13). Only Rev1,2
127A, Rev1 124,127A, and RV-infected cell lysates
showed binding to cav-1 residues 19-40 and 161-178
(Figure 4, lanes 1, 4, 5, 8, 11 and 12). Rev 2 bound cav19-40

and 161-178 as a monomer (~17 Kd, Figure 4 lanes 1 and 8).
With cav161-178, a NSP4 specific band at ~21 Kd (lane 8),
also was observed. Two rev2 mutants likewise bound both
cav-1 peptides (lanes 4, 5 and 11, 12), but only bound the
NSP4dimeric form. A larger dimer also was present in
lanes 5 and 12, further indicating the larger molecular
weight band is a multimeric form of NSP4. Together,
these data revealed that L116 is important for a proteinprotein interaction with cav-1.
Mutations within the amphipathic helix of NSP4 peptides
abolish diarrheagenic activity in mouse pups

Our previous study delineates the cav-1 binding site between NSP4 residues 114-135 (24). Hence, three peptides
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Figure 3 Representative Western blot analyses of yeast lysates co-transformed with NSP4 or NSP4 mutants with caveolin-1 fusion proteins.
The presence of NSP4- and cav-1 fusion proteins in the Y2H assay was shown by Western blot analyses of the yeast co-transformed with pD22cav-1
and each of the following fusion proteins: pD32NSP4 46-175 (lanes 2A and 2B), pD32NSP4-Ala6 (lanes 3A and 3B) , pD32NSP4-HydroMut (lane 4),
pD32Rev113I (lane 5), pD32Rev124V (lane 6), and pD32Rev131Y (lane 7). Lanes 8 and 9 show the FLNSP4-HydroMut and FLNSP4, respectively. Blots
were probed using (A) rabbit anti-NSP4150-175 or (B) rabbit anti-cav-12-31. Panel A: The non-transformed yeast (MaV203, lane 1) showed a non-specific
band at ~29 kD that was observed in all lanes. Lysates expressing FLNSP4-HydroMut (lane 8) demonstrated NSP4-specific bands at ~ 28, 24 kD.
Lysates expressing FLNSP4 showed bands at ~ 28, 24, and 20 kD (lane 9). All of the co-transformed yeast demonstrated a NSP4-fusion protein
band at ~ 34.4 kD (A, lanes 2-7). Panel B revealed a faint contaminating band below the 34.9 kD specific caveolin-1-fusion protein band (lanes 1-7).
Lanes 2-7 show the specific caveolin-1 fusion protein band at ~34.9 kD. Panel C: Lysates expressing FLNSP4 (lane 1) showed bands at ~ 24
and 28 kD and (lane 9). All of the co-transformed yeast demonstrated both monomeric and multimeric NSP4-specific fusion protein bands
(lanes 1). Rev2M116A, Rev2M116,124,127A, Rev1,2M127A and Rev1M124,127A revealed the ~34.9 kD specific NSP4-1-fusion protein band
(lanes 2-5). Also, Rev1M124,127A demonstrated a multimeric NSP4-fusion specific band similar to one observed with FLNSP4. Panel D:
Rev2M116A, Rev2M116,124,127A, Rev1,2M127A and Rev1M124,127A revealed a ~ 34.9 kD specific caveolin-1-fusion protein band (lanes 1-4).
Also, Rev1M124,127A demonstrated a multimeric caveolin-1-fusion protein band.

encompassing amino acids (aa) 112-140 of NSP4 were synthesized, which contained mutated residues in the hydrophobic (NSP4Hydro112-140), acidic (NSP4AlaAcidic112-140)
or basic (NSP4AlaBasic112-140) face of the amphipathic
alpha-helix (AAH). The sequences of each of the NSP4
mutant peptides are given in Additional file 1: Table S1.
NSP4Hydro112-140 contains three charged amino acids
(aa113, 124, 131) that were altered from the original hydrophobic residues. NSP4AlaAcidic112-140 and NSP4AlaBasic112-140
each contained three alanine residues substituted for negatively charged (aa114, 125, 132) and positively charged
(aa115, 119, 133) residues, respectively.
Balb/C mouse pups (6-10 days) were administered
wild type (wt) or mutant peptides by the intraperitoneal
route and monitored for diarrhea as previously described
[3]. Prior to injection, all purified peptide samples were
tested for endotoxin by the Limulus Amebocyte Lysate

(LAL) test (Associates of Cape Cod, Inc.) to ensure that
samples were endotoxin free. A value of 0.5 EU/mL or
less was considered acceptable for use in the diarrhea
studies. Mouse pups injected with endotoxin free PBS
served as a negative control. Mouse pups were monitored
for diarrhea every 2 hours for 12 hours and then at
24 hours post injection. The severity of the diarrhea was
scored on a scale of 1 to 4 (data not shown) (5). Following
injection, both the wt-NSP4112-140 and NSP4AlaAcidic112-140
peptides caused diarrhea in 50% and 67% of the mouse
pups tested, respectively (Additional file 1: Table S1).
NSP4Hydro112-140 and NSP4AlaBasic112-140 peptides, however,
did not induce diarrhea in any of the mouse pups tested.
These preliminary results suggest that residues within
both the hydrophobic face and the basic face of the
amphipathic alpha-helix of NSP4 are also important for
enterotoxic function.
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Figure 4 Western blot analyses of caveolin. Yeast lysates expressing Rev2; Rev2 116, 124,127A; Rev2 116A; Rev1,2 127A; Rev1,2 124,127A, and
NSP4HydroMut were incubated with CNBr-activated sepharose 4B beads bound by either the N-terminal (cav-119-40) (lanes 1-7) or C-terminal
(cav-1161-178) (lanes 8-14) peptides. Left Panel: Yeast lysates were reacted with bound cav-1 residues 19-40 and probed with rabbit anti-NSP4150-175.
Lanes 1, 4, and 5 depict the reactivity of Rev2; Rev1,2 127A; and Rev1,2 124,127A, respectively. Lanes 2, 3, 6, and 7 show a lack of reactivity with Rev2
116, 124,127A; Rev2 116A; NSP4HydroMut; and InVSc1 respectively. Right Panel: The same binding pattern was observed when the yeast lysates were incubated with cav-1161-178 (lanes 8-14). RV-infected MDCK cell lysates (lane 15) demonstrate the specificity of the rabbit anti-NSP4150-175. Non-specific binding
to the beads alone was not observed (data not shown). Lanes 4, 5, 11, and 12 show multimeric forms of NSP4.

The mutant NSP4 peptides had an altered secondary
structure when compared to NSP4 112-140wt

To determine any alteration in structure of the mutant
peptides, which may influence function, circular dichroism
(CD) was employed. CD spectra of the mutant NSP4
(mtNSP4) peptides in aqueous buffer differed from that
of the wild-type peptide (Figure 5B-D, dark circles). The

alpha-helical content was calculated based on the molar
ellipticity values at 222 nm. The NSP4HydroMut112-140 peptide seemed most affected by the mutations made in the
AAH, as the alpha-helical content was determined to
be 19.4 ± 2.2% (Additional file 1: Table S1). The mutations made in each of the charged faces of the AAH
had less of an effect on alpha-helix formation within the

Figure 5 CD spectra of NSP4 peptides in aqueous buffer (●) and 50% TFE (○). (A) wtNSP4112-140; (B) NSP4HydroMut112-140; (C) NSP4AlaAcidic112-140;
(D) NSP4AlaBasic112-140. X axis represents the wavelength (nm) and the y axis is the Molar Ellipticity (deg cm2 dmol-1).
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corresponding peptides. The alpha-helical content for the
NSP4AlaAcidic112-140 and NSP4AlaBasic112-140 peptides was
determined to be 23.7 ± 0.6% and 26.2 ± 2.9%, respectively (Additional file 1: Table S1).
In the presence of 50% trifluoroethanol (TFE, known
to promote a hydrophobic environment and to enhance
folding of synthetic peptides) each of the mutant NSP4
peptides increased in their alpha-helical secondary structure (2.5-3 times that in aqueous buffer) (Figure 5B-D,
open circles). As in aqueous buffer, the NSP4HydroMut112-140
peptide exhibited less alpha-helical formation (57.8 ± 0.6%)
than the NSP4AlaAcidic112-140 and NSP4AlaBasic112-140 peptides (73.1 ± 7.3% and 75.3 ± 2.8%, respectively) Additional
file 1: Table S1. Therefore, the mutations made within the
hydrophobic face of the AAH/cav-1 binding domain of
NSP4 most negatively affected the alpha-helix folding of
the peptide. Mutation of residues within the charged faces,
however, only had a slight affect (NSP4AlaAcidic112-140) or no
affect (NSP4AlaBasic112-140) on the alpha-helix structure of
the peptides.
Conservation of key NSP4 residues between different
RV strains

NSP4 amino acids 113-135 obtained from GenBank
of twelve RV strains that represent groups A through
E. (accession no. ABZ04174, BAA24144, ABZ04170,
BAB83830, AAA64924, AAL11029, AAB58698, AAD
50676, ABV66094, BAA13728, P08434, AND P04512)
were aligned with CLUSTAL (Figure 6). The following
observations were made: (i) all aligned sequences included I113 and L127 except Human RV C I113M and
L127K; (ii) all twelve strains contained L116; (iii) position
124 was V with one exception, Human RV C V124D;
(iv) L134 was conserved with the exception of EDIM
L134M and Human RV C L134I, another hydrophobic
amino acid; and the residue 131 varied from Y131, H131
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(NCDV, OSU, Wa, RRV), S131 (Human RV C). The high
similarity of I113, L116, V124, L127, and L134 infer the
importance of these residues. Given the high sequence
divergence recently reported in NSP4 sequences, the conservation of the hydrophobic residues is all the more
remarkable [44].

Methods
Antibodies

NSP4 and cav-1 peptide-specific antibodies were generated in New Zealand white rabbits to NSP4 residues
150-175 and cav-1 residues 2-31, respectively, following
established protocols (5). Antibodies were purified against
the peptide and used as primary antibodies in Western
blots as previously described [25]. All primary antibodies
were detected by horseradish peroxidase (HRPO)-labeled
goat anti-rabbit IgG (Pierce, Rockford, Il).
Mammalian cell lines and yeast strains

MDCK cells were obtained from ATCC (Rockville, MD)
and maintained in Dulbecco modified Eagle medium
(DMEM; Gibco, Grand Island, NY) supplemented with
10% fetal bovine serum (FBS), glutamine (2 mM),
penicillin-streptomycin (100 ug/ml) and non-essential
aa (1×) (Sigma, St. Louis, MO). To compare the NSP4
expressed in yeast to that expressed in RV-infected mammalian cells, MDCK cells were infected with RV SA114F,
lysates were collected, and subjected to Endo H digestion
as previously described [45,46]. The cell lysates also were
utilized as a positive control with the pulldown assays.
Saccharomyces cerevisiae strain MaV203 (MATα, leu23,112, trp1-901, his3Δ200, ade2-101, gal4Δ, gal80Δ,
SPAL10::URA3, GAL1::lacZ, HIS3UAS GAL1::HIS3@LYS2,
can1r, cyh2r) was used for all Y2H analyses [43,45,46]. A
collection of yeast strains that contain plasmid pairs
expressing fusion proteins with a spectrum of interaction
strengths [pPC97 (GAL4-DB, LEU2), pPC97-CYH2S and
pPC86 (GAL4-AD, TRP1)] were used as controls [43,47].
The control plasmids pDBleu and pEXP-AD507 contain only the Gal4 DNA-binding domain (BD) and the
Gal4 activating-domain (AD) respectively. The S. cerevisiae yeast strain InVSc1 (MATα his3-Δ1, leu2, trp1-289,
ura3-52; Invitrogen) was used to express native and mutant NSP4 proteins that were used in peptide binding
studies.
NSP4 cloning strategy

Figure 6 Rotavirus NSP4 protein alignments. NSP4 protein
sequences obtained from GenBank of twelve rotavirus strains that
represent groups A through E. [GenBank: ABZ04174, BAA24144,
ABZ04170, BAB83830, AAA64924, AAL11029, AAB58698, AAD50676,
ABV66094, BAA13728, P08434, AND P04512] were aligned with
CLUSTALW for multiple sequence alignments [51,52].

PCR products of NSP4 (residues 46-175), NSP4Ala6 and
NSP4HydroMut constructs were directionally cloned into
the Invitrogen Gateway™ Entry vector (pENTR11, Invitrogen, CA), sequence verified, and cloned into the Invitrogen Gateway™ destination vectors, pDEST22 and
pDEST32, as previously described [25,43,48]. All plasmid
manipulations were performed according to standard
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protocols in the Escherichia coli strains DH5α as described in the Gateway™ System manual [49].
To further refine the specific NSP4-cav-1 binding site,
seven NSP446-175 mutants were constructed and sequence
verified (Rev113I, Rev124V, Rev131Y, Rev116,124,127A,
Rev124V,116A, Rev113I,124 V,127A and Rev113I,124
V,127A, Table 1 and Figure 1C). The three amino acids
mutated in NSP4HydroMut (I113R, V124K and Y131D) were
individually reverted back to the original amino acid
(Rev1-I113; Rev2-V124; and Rev3-Y131; Figure 1C). The
next four mutants were derived from combinations of alanine substitutions and reverting charge amino acid to the
original hydrophobic amino acids in Rev2. Alanines were
used to minimize conformational and structural disruption
of the hydrophobic face of the AAH.
Yeast two-hybrid screening

The MaV203 yeast strain was co-transformed with cav-1
and one of the NSP4 constructs (FLNSP4, FLNSP4-Ala6,
FLNSP4-HydroMut, NSP446-175, NSP4Ala6, NSP4HydroMut,
Rev1, Rev2, Rev3, Rev2 116,124,127A, Rev2 116A, Rev1,2
127A, and Rev1 124,127A) in the appropriate pD22 and
pD32 vectors by a modified lithium acetate procedure as
previously described [25,47]. Briefly, S. cerevisiae MaV203
was grown in YPAD overnight at 30°C, diluted to an
OD600 of 0.5, and incubated at 30°C with shaking to an
OD600 of 2. The cells were washed with dH2O, centrifuged,
and washed with 1 ml of 100 mM lithium acetate (LiAc),
centrifuged and resuspended in 100 mM LiAc. Aliquots
were centrifuged and the following solutions were added in
order: 240 μL of 50% PEG (3350 mw); 36 μL of 1 M LiAc;
25 μL of salmon sperm DNA (2 mg/ml); 50 μL of dH2O;
and 100 ng of each plasmid DNA. The yeast were shocked
at 42°C for 45 min and then incubated at 30°C for 1 h before plating onto complete synthetic medium lacking leucine and tryptophan (CSM Leu-Trp-).
The transformed yeast colonies were grown at 30°C
for 3 days on CSM Leu-Trp- to identify colonies containing both plasmids. The activation of transcription of
three independent reporter genes (URA, His3,lacZ) were
monitored by the observation of yeast growth patterns
on specific media. URA3 was monitored by cell growth
patterns on CSM Leu-Trp-Ura- and CSM Leu-Trp- +
0.2% 5-fluoroorotic acid (FOA); 5FOA inhibits the
growth of yeast. When HIS3 was transcribed, the growth
of the co-transformed yeast was inhibited in a dosedependent manner by adding 3-amino-1, 2, 4-triazole
(3AT) to CSM Leu-Trp-His- [50]. MaV203 expresses a
basal level of HIS3 that was suppressed with increasing
concentrations of 3AT to allow discrimination of HIS3
activation.
Activation of the lacZ promoter was detected with a
qualitative assay using the substrate X-gal (5-bromo-4chloro-3-indolyl-β-D-galactopyranoside). To quantitatively

Page 11 of 15

measure beta-galactosidase activity, chlorophenol redbeta-D-galactopyranoside (CPRG) was used for the
substrate as described in the ProQuest™ Two Hybrid
System manual [25,47].
Expression of FLNSP4, NSP446-175 and a panel
of NSP4 mutants

The entry vectors encoding FLNSP4, FLNSP4-Ala6,
FLNSP4-HydroMut, and NSP446-175 were used to shuttle
the NSP4 sequences into the inducible yeast expression
plasmid, pYES-DEST52 (Invitrogen) and transformed into
the inducible yeast strain, InVSc-1 [25]. Since our previous
data demonstrate stronger binding of NSP4 to cav-1 in
Y2H assays when the first two NSP4 N-terminal hydrophobic domains are deleted, we continued our experiments
with the truncated NSP4 [25] and constructed NSP4Ala6
and NSP4HydroMut for use in the Y2H experiments. All additional mutants (Rev1, Rev2, Rev3, Rev2 116,124,127A,
Rev2 116A, Rev1,2 127A, and Rev1 124,127A) were constructed using site directed mutagenesis of NSP446-175, introduced into the Gateway® entry vector, and cloned into
the inducible yeast expression plasmid, pYES-DEST52, as
above (Table 1). The transformed yeast colonies were
grown on CSM Ura- and the encoded NSP4 proteins
were induced with YPAG medium yeast extract, peptone
(Difco), 0.01% adenine sulfate and 2% galactose (Sigma).
Cells were grown in YPAD at 30°C for 24 h, washed and
re-suspended to an OD600 of 0.5 in YPAG and incubated
at 30°C for 24 h. Yeast lysates were prepared using the
Zymo Yeast Protein Extraction kit (Zymo Research,
Orange, CA) as previously described and were utilized in
the binding assays [25]. Approximately 1 × 106 cells were
pelleted, Y-Lysis buffer and zymolase were added to the
samples and incubated at 37°C for 1 h. The yeast were centrifuged at 400×g for 5 min, resuspended in PBS (pH 7.2),
containing protease inhibitors 100 μM AEBSF, 80 μM
aprotinin, 5 μM bestatin, 1.5 μM E-64, 2 μM leupeptin, 1 μM pepstatin A and 100 μM PMSF (CalbiochemNovabiochem Corp., San Diego, CA)] and quantified by
BCA (Pierce). These lysates were used in the in vitro peptide binding and Western blot assays as described below.
Peptide synthesis, purification and characterization

All peptides were synthesized by fluorenylmethoxycarbonyl (Fmoc) solid-phase chemistry with either 1hydroxy-benzotriazole (HOBt), O-Benzotriazole-N,N,
N’,N’-tetramethyluronium-hexafluoro-phosphate (HBTU)
and N,N-diisopropylethylamine (DIPEA), or HOBt and
N,N’-diisopropylcarbodiimide (DIPCIDI) activation using
the Model 90 Peptide Synthesizer (Advanced Chemtech/
AAPTEC; Louisville, KY) as previously reported [32]. Following synthesis, the peptides were cleaved from the solid
resin support and all side-chain protecting groups removed
by addition of Reagent R (90% trifluoroacetic acid (TFA),
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5% thioanisole, 3% ethanedithiol and 2% anisole). Peptides
were separated from the solid support by filtration into
cold diethyl ether in a dry ice/ethanol bath. Following three
organic precipitations, peptides were purified from organic contaminants and incomplete peptide fragments
by gravimetric gel filtration chromatography (Sephadex
G25 medium) and reverse-phase HPLC using a reverse
phase C4 Delta Pak (Waters Chromatography Division,
Milford, MA) or C18 (Beckman-Coulter, Fullerton, CA)
column. Peptide characterization was by matrix-assisted
laser desorption/ionization (MALDI) mass spectrometry
(Laboratory for Biological Mass Spectrometry, Department
of Chemistry, Texas A&M University, College Station, TX).
Mass chromatograms revealed if the full-length peptide
was present, the mass of the peptide and the extent of contaminants in the eluted fraction.
All purified peptide samples were tested for endotoxin
by the Limulus Amebocyte Lysate (LAL) test (Associates
of Cape Cod, Inc.) according to the manufacturer’s protocol, to ensure that the samples were endotoxin free. A
value of 0.5 EU/mL or less was considered acceptable for
use in the diarrhea studies.
Diarrhea induction in mouse pups

To examine the biological relevance (enterotoxic activity)
of the mutations made in the hydrophobic face of
the amphipathic alpha-helix/enterotoxic peptide/cav-1
binding domain of NSP4, the NSP4HydroMut112-140,
NSP4AlaAcidic112-140, NSP4AlaBasic112-140 and the wtNSP4112-140 peptides were tested for diarrhea induction as
previously described (5, 54) (Additional file 1: Table S1).
Briefly, each of the NSP4-specific peptides (100 nmol
in 50 μl total volume) was administered by intraperitoneal (IP) delivery to 6-10 day old mouse pups (5-6 pups
per peptide). Mouse pups injected with endotoxin-free
PBS served as a negative control. Mouse pups were
monitored for diarrhea every 2 hours for 12 hours
and then at 24 hours post injection. The severity of the
diarrhea was scored on a scale of 1 to 4 as previously
described (5).
Western blot assays

The co-transformed yeast colonies were grown in liquid
CSM Leu- Trp-, and yeast protein extracts were prepared
using the Zymo Yeast Protein Extraction kit (Zymo
Research, CA). The cell pellets were resuspended in
PBS (pH 7.2) containing protease inhibitors and quantified by BCA (Pierce). All lysates were separated by 12%
SDS-PAGE, electroblotted onto nitrocellulose membranes, probed with NSP4 or cav-1 peptide-specific antibodies, and reactive bands visualized by the addition of
HRP-conjugated IgG and Super Signal® West Pico chemiluminescent substrate (Pierce) followed by exposure to
Kodak X-OMAT film [51,52].
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Alignment of NSP4 amino acid sequences

To determine which amino acids in NSP4 residues
113-135 were conserved in different viral strains that
encompass RV groups A through E, an alignment was
generated of RV sequences obtained from [GenBank:
ABZ04174, BAA24144, ABZ04170, BAB83830, AAA64924,
AAL11029, AAB58698, AAD50676, ABV66094, BAA13728,
P08434, AND P04512]. The sequences were aligned using
SDSC Biology Workbench (http://workbench.sdsc.edu)
with CLUSTALW for multiple sequence alignments [51].
The percent identities with respect to SA11 were deduced
using MView 1.4 [53].

Discussion
This study demonstrated that the hydrophobic face of
the AAH of the enterotoxic domain of NSP4 is critical
for the binding to cav-1 and structure may play a role.
An NSP4 construct that disrupted the charged face of
the amphipathic helix (NSP4-Ala6) continued to bind
cav-1, but alteration of three residues (I113R, V124K,
Y131D) in the hydrophobic face disrupted cav-1 binding
(NSP4-HydroMut). When any one of the three mutated
hydrophobic amino acids was restored, NSP4 binding to
cav-1 was restored as observed with the Y2H and peptide binding assays. We had not anticipated that all three
hydrophobic amino acids selected for mutation in NSP4HydroMut would individually restore the binding to cav-1,
but anticipated reversion of more than one of the three
mutated residues would be required to reconstitute the
binding site. All three revertants included L116 and L127
suggesting these hydrophobic residues were critical
to cav-1 binding. Further analysis of L116 and L127, using
the revertant mutants that substituted L116A and/or
L127A identified L116 as a key residue for NSP4 binding
to cav-1. The ability of L116 to bind cav-1 changes the reactivity from binding in native NSP4 to not binding in
NSP4HydroMut, to binding in the Rev 2 and finally to not
binding in Rev2 with mutated L116A (Figure 1C).
Yet, NSP4HydroMut contained L116 and failed to bind
cav-1, suggesting more than one amino acid is required to
accomplish binding. Protein-protein interactions can rely
on the recognition of linear motifs yet, binding sites frequently depend on (a) exposure of the binding motif at the
surface of the protein; (b) the environment of the binding
residues; and (c) may require conformation-dependent epitopes for binding [54]. Given that the binding site is within
the hydrophobic face, typical protein folding patterns
would not place these residues on the protein surface, but
would protect them from the aqueous environment of the
cell. Perhaps the NSP4-cav-1 binding site was dependent
on the secondary structure of a region that included L116
that was disrupted in the NSP4HydroMut. The CD analysis
confirmed that the NSP4HydroMut peptide has a different
secondary structure than the NSP4 wild type peptide.

Ball et al. Virology Journal 2013, 10:336
http://www.virologyj.com/content/10/1/336

Notably the identified NSP4 residue that binds cav-1
overlaps the enterotoxic peptide. To begin to understand
the functional connection between NSP4 enterotoxic activity and cav-1 binding, diarrhea induction in neonatal
mice was evaluated with peptides corresponding to the
wt-NSP4112-140, NSP4AlaAcidic112-140, NSP4HydroMut112-140
and NSP4AlaBasic112-140. The NSP4AlaBasic112-140 and
NSP4HydroMut112-140 peptides failed to induce diarrhea,
whereas when three acidic residues were altered to alanines, NSP4AlaAcidic112-140, diarrhea was induced, similar to the wild type peptide. As the CD analysis of
NSP4AlaAcidic112-140 and NSP4AlaBasic112-140 indicated disruption of the AAH, the helix appeared to tolerate
changes in the charged face. Computer modeling of the
mutants using PyMol showed constraints for structure
especially with I113R (data not shown). These data support the model that the integrity of the secondary structure of the hydrophobic face of the AAH of NSP4 may be
important for the induction of diarrhea.
Despite our diarrhea data, it is unclear if cav-1 binding
in itself plays a role in diarrhea induction or if cav-1 directs NSP4 to caveolae for signal induction. A previous
study highlighted the importance of the tyrosine residue
in the hydrophobic face of the AAH. A synthetic peptide
in which the tyrosine residue was mutated to a lysine
lacked diarrhea-inducing function [55]. In this study,
when tyrosine was changed to aspartic acid (D), NSP4
failed to induce diarrhea. Although Y131 is important
for the induction of diarrhea in some but not all strains
of RV [55], Y131 appears to be dispensable for cav-1
binding. Both Rev1 and Rev2 bind cav-1 in the absence
of Y131, and the lack of Y131 does not influence cav-1
binding of Rev1,2 127A or Rev1 124,127A. Our data
herein supports and further suggests that the structure
of the AAH of NSP4 may play a significant role in promoting diarrhea.
A recent study revealed that the α1β1 integrins are receptors for NSP4 [12]. Binding to these receptors initiates cellular signaling processes (in particular, activation
of phospholipase C) that mobilize calcium and result in
diarrhea induction. While NSP4 binds the integrin receptor at residues 114-135, signaling occurs via an interaction between NSP4 131-140 and a separate integrin
domain [12]. NSP4 HydroMut112-140 contains a mutation
at aa131, which is within the integrin signaling domain,
and does not cause diarrhea. Lack of enterotoxic function with this mutant peptide may be a result of its inability to initiate integrin mediated signaling. These
results agree with previous data demonstrating that the
exogenous addition of NSP4 mobilizes [Ca2++]I from ER
stores through a phospholipase C-inositol 1,4,5-triphosphate (PLC-IP3) pathway [6].
The data presented suggested that the integrity of the
hydrophobic face of NSP4 was critical to both cav-1
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binding and modulating diarrhea induction. Localization
of the binding site to the conserved hydrophobic residues
between RV strains and the lack of diarrhea induced by
the synthesized peptide with the corresponding mutations
in the hydrophobic face of NSP4 indicated the importance
of the cav-1 binding site of NSP4. However, the lack of
diarrhea observed with the peptide NSP4AlaBasic112-140 indicated that the NSP4 enterotoxin might extend into the
basic face. Additional studies are needed to dissect the
complexity of NSP4’s multiple activities and binding domains, and how these domains are coordinated during a
viral infection.
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